FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
News Details - Moderna
WEBMar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
Moderna Advances Multiple Vaccine Programs to Late-Stage …
WEBMar 27, 2024 · Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials. Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3 endpoints. Expects two more Phase 3 readouts in 2024, including combination vaccine against flu and COVID-19, and vaccine against CMV.
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
WEBSep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines …
FDA Takes Action on Updated mRNA COVID-19 Vaccines to …
WEBSep 11, 2023 · FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
Moderna, Pfizer say updated Covid vaccines were effective …
WEBSep 6, 2023 · New Covid vaccines from Moderna and Pfizer produced a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, the companies said ...
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine - Moderna
WEBI am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved our supplemental Biologics License Application (sBLA) for Spikevax® (COVID-19 Vaccine, mRNA) for individuals 12 years of age and older, which helps protect against the most dominant variants as recommended by the June 2023 FDA VRBPAC.
The Moderna COVID-19 (mRNA-1273) vaccine: what you need …
WEBAug 18, 2022 · The Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.
Moderna COVID-19 Vaccine | FDA
WEBNov 1, 2023 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older.
The FDA just approved the new Covid vaccine: When to get it ... - NBC News
WEBAug 22, 2024 · Pfizer, Moderna and Novavax are charging up to $150 per dose for a Covid vaccine, according to data from the Centers for Medicare and Medicaid Services.
Skip to content